Campos Marc, Schiopu Elena
Division of Rheumatology, University of Michigan, P.O. Box 481, Ann Arbor, MI 48109, USA.
Case Rep Rheumatol. 2012;2012:537613. doi: 10.1155/2012/537613. Epub 2012 Aug 29.
Adult-onset Still's disease (AOSD) is a rare inflammatory condition characterized by spiking quotidian fever, rash, chronic arthralgia, leukocytosis, and occasional pulmonary involvement such as pleural effusion and transient pulmonary infiltrates. Pulmonary arterial hypertension (PAH) is a rare pulmonary complication of AOSD, and we are aware of only 5 cases reported in the literature. We report the case of a 27-year-old woman of Middle Eastern descent, with a 7-year history of AOSD, who developed severe pulmonary arterial hypertension (PAH). After unsuccessful exposure to various immunosuppressive regimens, shortly following the initiation of anakinra, an interleukin-1 (IL-1) receptor antagonist, her disease became quiescent and the PAH resolved. With this case report, we hope to show that anakinra, either by virtue of controlling the overall inflammation in AOSD, or by direct effect on the pulmonary microangiopathy, can improve severe PAH.
成人斯蒂尔病(AOSD)是一种罕见的炎症性疾病,其特征为每日出现高热、皮疹、慢性关节痛、白细胞增多,以及偶尔出现的肺部受累,如胸腔积液和短暂性肺部浸润。肺动脉高压(PAH)是AOSD一种罕见的肺部并发症,据我们所知,文献中仅报道过5例。我们报告了一例27岁中东裔女性,患有AOSD 7年,出现了严重的肺动脉高压(PAH)。在尝试多种免疫抑制方案均未成功后,在开始使用白细胞介素-1(IL-1)受体拮抗剂阿那白滞素后不久,她的病情得到缓解,PAH也消失了。通过本病例报告,我们希望表明,阿那白滞素要么通过控制AOSD的整体炎症,要么通过对肺微血管病变的直接作用,可以改善严重的PAH。